Peptide Stack
Wolverine stack
A two-compound injury-recovery stack used to support soft-tissue repair, tendon recovery, and regeneration-focused wellness protocols.
In depth
Why these two compounds are paired
The "Wolverine stack" pairs BPC-157 and TB-500 (thymosin beta-4) because their proposed mechanisms are complementary rather than overlapping: BPC-157's research centers on localized angiogenesis and growth-factor signaling at injury sites, while TB-500's centers on cell migration and systemic anti-inflammatory signaling via G-actin binding. The combination is popular in soft-tissue-recovery contexts precisely because the two don't compete for the same receptor pathway.
Neither compound has strong human clinical trial support for this specific use on its own, and there is no dedicated clinical research on the combination itself — the rationale is inferred from each compound's separate preclinical literature, not from a trial of the stack as a whole.
Safety considerations for stacking
Since neither compound is FDA approved, combining them means combining two largely uncharacterized human safety profiles rather than one — the interaction itself, not just each compound alone, is essentially unstudied.
Detail
Overview
A two-compound injury-recovery stack used to support soft-tissue repair, tendon recovery, and regeneration-focused wellness protocols.
Benefits, side effects, and protocols
Benefits list
- May support soft-tissue repair
- May aid tendon recovery
- Recovery-focused repair support
Side effects
- Injection site reactions
- Limited human safety data
- Potential immune effects
Vendor protocol
- BPC-157 250-500 mcg SC daily near injury
- TB-500 2-5 mg SC twice weekly
Clinical protocol
- No standard clinical protocol; the BPC-157 + TB-500 combination has not been tested directly in clinical trials
Evidence
- Low
Regulatory
- Not Fda Approved
Research
Mechanisms
Evidence notes
- Low
Administration
Research links
- None listed
Contraindications
- None listed
Components
Regulatory data
- Not Fda Approved
Aliases
- bpc-157 + tb-500
- bpc-157 tb-500 stack
- wolverine stack 2-compound
Related compounds
Guides that cover Wolverine stack
BPC-157 is one of the most confidently discussed peptides on the internet. PubMed indexes no completed randomized controlled trial of it in humans. Here is what does exist, and what it can support.
TB-500 is a fragment of thymosin beta-4, and the human trials people cite for it were run on the full-length protein. Here is what each has actually been shown to do.
Terminology on this page
Concepts from the glossary that come up around Wolverine stack.
Frequently asked questions
What is the Wolverine stack?
It is a combination of BPC-157 and TB-500 (thymosin beta-4), two research peptides studied separately for soft-tissue healing, paired together on the theory that their mechanisms are complementary. The name references the fictional character's rapid healing rather than any clinical claim.
Is there research on the Wolverine stack specifically?
No dedicated clinical trial has studied the BPC-157 and TB-500 combination as a stack. The rationale is drawn from the separate (mostly preclinical) literature on each compound individually.
Is the Wolverine stack safe?
Since neither compound is FDA approved and there is no combined-safety data, it carries the uncertainty of each individual compound plus the unknown of using them together.
Educational reference only. Pepperz does not provide medical advice, diagnosis, treatment, prescribing guidance, or dosing recommendations. Sourcing Wolverine stack? Check your source before you use anything.